We demonstrated that the stem cell quiescence and TKI resistance displayed by CML stem cells in vivo are sustained by the Gdpd3 enzyme involved in lysophospholipid metabolism. The gene discussed is GDPD3; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.